Literature DB >> 12526815

Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear.

Gleb P Shumyatsky1, Evgeny Tsvetkov, Gaël Malleret, Svetlana Vronskaya, Michael Hatton, Lori Hampton, James F Battey, Catherine Dulac, Eric R Kandel, Vadim Y Bolshakov.   

Abstract

We identified the Grp gene, encoding gastrin-releasing peptide, as being highly expressed both in the lateral nucleus of the amygdala, the nucleus where associations for Pavlovian learned fear are formed, and in the regions that convey fearful auditory information to the lateral nucleus. Moreover, we found that GRP receptor (GRPR) is expressed in GABAergic interneurons of the lateral nucleus. GRP excites these interneurons and increases their inhibition of principal neurons. GRPR-deficient mice showed decreased inhibition of principal neurons by the interneurons, enhanced long-term potentiation (LTP), and greater and more persistent long-term fear memory. By contrast, these mice performed normally in hippocampus-dependent Morris maze. These experiments provide genetic evidence that GRP and its neural circuitry operate as a negative feedback regulating fear and establish a causal relationship between Grpr gene expression, LTP, and amygdala-dependent memory for fear.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12526815     DOI: 10.1016/s0092-8674(02)01116-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  91 in total

1.  Context-dependent neuronal activity in the lateral amygdala represents fear memories after extinction.

Authors:  Jennifer A Hobin; Ki A Goosens; Stephen Maren
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

2.  Postnatal maturation of GABAergic modulation of sensory inputs onto lateral amygdala principal neurons.

Authors:  Daniel Bosch; Ingrid Ehrlich
Journal:  J Physiol       Date:  2015-08-30       Impact factor: 5.182

3.  Zinc transporter 3 is involved in learned fear and extinction, but not in innate fear.

Authors:  Guillaume Martel; Charles Hevi; Olivia Friebely; Trevor Baybutt; Gleb P Shumyatsky
Journal:  Learn Mem       Date:  2010-10-29       Impact factor: 2.460

4.  Effects of reinforcement schedule on facilitation of operant extinction by chlordiazepoxide.

Authors:  Julian C Leslie; David Shaw; Gillian Gregg; Nichola McCormick; David S Reynolds; Gerard R Dawson
Journal:  J Exp Anal Behav       Date:  2005-11       Impact factor: 2.468

5.  Spatiotemporal asymmetry of associative synaptic plasticity in fear conditioning pathways.

Authors:  Ryong-Moon Shin; Evgeny Tsvetkov; Vadim Y Bolshakov
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

Review 6.  The promise of extinction research for the prevention and treatment of anxiety disorders.

Authors:  Kathleen C Anderson; Thomas R Insel
Journal:  Biol Psychiatry       Date:  2006-08-15       Impact factor: 13.382

7.  Antagonism of lateral amygdala alpha1-adrenergic receptors facilitates fear conditioning and long-term potentiation.

Authors:  Stephanie C Lazzaro; Mian Hou; Catarina Cunha; Joseph E LeDoux; Christopher K Cain
Journal:  Learn Mem       Date:  2010-09-24       Impact factor: 2.460

8.  Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR).

Authors:  L J Strug; R Suresh; A J Fyer; A Talati; P B Adams; W Li; S E Hodge; T C Gilliam; M M Weissman
Journal:  Mol Psychiatry       Date:  2008-07-29       Impact factor: 15.992

9.  Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat.

Authors:  Christine Mountney; Hymie Anisman; Zul Merali
Journal:  Psychopharmacology (Berl)       Date:  2008-06-18       Impact factor: 4.530

10.  Normal hearing is required for the emergence of long-lasting inhibitory potentiation in cortex.

Authors:  Han Xu; Vibhakar C Kotak; Dan H Sanes
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.